跳至主要内容
临床试验/NCT01359917
NCT01359917已完成不适用

Psychological Morbidity and Facial Volume in HIV Lipodystrophy:

NHS Lothian0 个研究点目标入组 50 人开始时间: 2006年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
NHS Lothian
入组人数
50
主要终点
measurement of 3-D facial volume

研究概览

简要总结

The hypotheses of this study were that:

  1. HIV lipodystrophy is associated with psychological morbidity relating to body image, anxiety and depression.
  2. Treatment of HIV lipodystrophy using autologous fat transfer, polylactic acid or Bio-alcamid, is associated with an improvement in psychological morbidity and anatomical volume of treated areas.
  3. The DI3D system is a valid and reproducible method of recording and measuring facial 3-D volume.

详细描述

as above

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • HIV facial lipoatrophy
  • concurrent antiretrovirals

排除标准

  • known psychological disorder
  • skin allergies
  • significant medical problems precluding anaesthesia

结局指标

主要结局

measurement of 3-D facial volume

时间窗: 2 years

3-D facial camera

次要结局

  • psychological outcome(2 years)

研究者

发起方
NHS Lothian
申办方类型
Other Gov

相似试验